S&P 500 Futures
(0.19%) 5 141.50 points
Dow Jones Futures
(0.13%) 38 490 points
Nasdaq Futures
(0.28%) 17 896 points
Oil
(0.00%) $83.85
Gas
(0.88%) $1.940
Gold
(0.28%) $2 353.70
Silver
(0.58%) $27.70
Platinum
(2.16%) $942.00
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.32%) $10.99
USD/GBP
(-0.29%) $0.798
USD/RUB
(1.25%) $93.03

实时更新: ALK-Abelló A/S [AKABY]

交易所: OTC 部门: Healthcare 工业: Biotechnology
最后更新时间1 Jan 1970 @ 08:00

0.00% $ 90.00

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar...

Stats
今日成交量 309.00
平均成交量 23.00
市值 0.00
Last Dividend $0.145 ( 2017-03-15 )
Next Dividend $0 ( N/A )
P/E 3 000.00
ATR14 $0 (0.00%)

ALK-Abelló A/S 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ALK-Abelló A/S 财务报表

Annual 2021
营收: $3.92B
毛利润: $2.40B (61.18 %)
EPS: $0.200
FY 2021
营收: $3.92B
毛利润: $2.40B (61.18 %)
EPS: $0.200
FY 2020
营收: $3.49B
毛利润: $2.03B (58.09 %)
EPS: $0.0229
FY 2019
营收: $3.27B
毛利润: $1.89B (57.79 %)
EPS: $-0.0459

Financial Reports:

No articles found.

ALK-Abelló A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

ALK-Abelló A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.33 - good (83.35%) | Divividend Growth Potential Score: 2.89 - No dividend growth expected in the near future
Information
First Dividend $0.152 2015-03-25
Last Dividend $0.145 2017-03-15
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out $0.448 --
Avg. Dividend % Per Year 0.00% --
Score 2.21 --
Div. Sustainability Score 8.33
Div.Growth Potential Score 2.89
Div. Directional Score 5.61 --
Next Divdend (Est)
(2024-12-30)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.21
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
XNGSY Ex Dividend Junior 2023-11-02 Annually 0 0.00%
MKKGY Ex Dividend Knight 2023-05-02 Annually 0 0.00%
CNLPL Ex Dividend Knight 2023-09-07 Quarterly 0 0.00%
SRCU Ex Dividend Junior 2023-08-14 Quarterly 0 0.00%
HHULY Ex Dividend Junior 2023-06-15 Annually 0 0.00%
ARKAY Ex Dividend Junior 2023-05-11 Annually 0 0.00%
NXGPY Ex Dividend Knight 2023-07-06 Semi-Annually 0 0.00%
DANOY Ex Dividend Junior 2023-05-05 Annually 0 0.00%
TLGHY Ex Dividend Junior 2023-05-03 Annually 0 0.00%
IMBBY Ex Dividend Knight 2023-08-17 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05591.5008.8810.00[0 - 0.5]
returnOnAssetsTTM0.03761.2008.7510.00[0 - 0.3]
returnOnEquityTTM0.06601.500-0.377-0.566[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.7350.8006.325.06[1 - 3]
quickRatioTTM0.1400.800-3.88-3.11[0.8 - 2.5]
cashRatioTTM0.1401.500-0.333-0.499[0.2 - 2]
debtRatioTTM0.122-1.5007.97-10.00[0 - 0.6]
interestCoverageTTM13.131.0006.256.25[3 - 30]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
freeCashFlowPerShareTTM0.1862.009.9110.00[0 - 20]
debtEquityRatioTTM0.204-1.5009.18-10.00[0 - 2.5]
grossProfitMarginTTM0.6121.0003.143.14[0.2 - 0.8]
operatingProfitMarginTTM0.07711.000-0.458-0.458[0.1 - 0.6]
cashFlowToDebtRatioTTM0.6591.0007.457.45[0.2 - 2]
assetTurnoverTTM0.6720.8008.867.08[0.5 - 2]
Total Score8.33

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3 141.111.00010.000[1 - 100]
returnOnEquityTTM0.06602.50-0.243-0.566[0.1 - 1.5]
freeCashFlowPerShareTTM0.1862.009.9410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-22.591.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1201.0009.510[0.1 - 0.5]
Total Score2.89

ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。